Improvements in Personalized Medicine Allow for Greater Exploration of Treatment De-escalation in Breast Cancer

Suzanne B. Coopey, MD, FACS, discusses the de-escalation of axillary lymph node surgery, shifts in the use of radiation oncology, and changes in the treatment paradigm for HER2-positive breast cancer.

Related Keywords

Meadville ,Pennsylvania ,United States ,Wexford ,Sarahm Miller ,Gurleen Pasricha ,Suzanneb Coopey ,Coline Champ ,Christiej Hilton ,Dianem Buchbarker ,Allegheny Health Network ,Wexford Breast Program ,Meadville Medical Center ,Breast Cancer Program ,Cancer Institute In Wexford ,Science Summit ,Choosing Wisely ,Meadville Medical ,De Escalation Of Axillary Lymph Node Surgery ,D ,Pacs ,Biomarker Testing In Triple Negative Breast Cancer ,Her2 Negative Breast Cancer ,Patients With Breast Cancer ,Axillary Reverse Mapping ,Primary Lymphovenous Bypass ,O ,Her2 Positive Metastatic Breast Cancer ,Early Stage Her2 Positive Breast Cancer ,Her Positive ,